Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis

Clinical trial NCT04847453 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04847453
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent AL Amyloidosis Refractory AL Amyloidosis

Start date: 2022-08-03
Primary completion: 2028-06-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.